The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
Nanoscale materials are defined as a set of substances where at least one dimension is less than approximately 100 nanometers. A nanometer is one millionth of a millimeter - approximately 100,000 times smaller than the diameter of a human hair. Nanomaterials such as silver and gold nanoparticle are of interest because at this scale unique optical, magnetic, electrical, and other properties emerge. These emergent properties have the potential for great impacts in electronics, medicine, and other fields. The production of nanophase or cluster-assembled materials is usually based upon the creation of separated small clusters which then are fused into a bulk-like material like micelles/liposomes or on their embedding into compact liquid or solid matrix materials.
- Track 1-1Fullerenes
- Track 1-2Single Walled Carbon Nanotubes
- Track 1-3Double Walled Carbon Nanotubes
- Track 1-4Inorganic Nanoparticles
- Track 1-5Super Paramagnetic Nanoparticles
- Track 1-6Silver Nanoparticles
- Track 1-7Other types of Biocompatible Nanoparticles
- Track 1-8Micelles and Liposomes
- Track 1-9Dendrimers
- Track 1-10Nanochemistry
A biomaterial is any substance that has processed and engineered to connect with organic frameworks for a medicinal reason - either a helpful (treat, enlarge, repair or supplant a tissue capacity of the body) or an analytic one. As a science, biomaterials is around fifty years of age. It has encountered enduring and solid development over its history, with many organizations putting a lot of cash into the advancement of novel items. Biomaterials science incorporates components of solution, science, tissue designing and materials science. A biomaterial is unique in relation to a natural material, for example, bone, that is delivered by an organic framework.
- Track 2-1Biomaterials Processing and Engineering
- Track 2-2Polymer based Nanomedicine for Targeted Therapy
- Track 2-3Nanoengineering Bioanalogous Structure
- Track 2-4New and Classical Material for Biomedical Use
Nanomedicine science opens a new pool of opportunities for emerging new technologies in order to diagnose and treat fatal diseases, one of them being nanotechnology in cancer treatment. New nanotechnology enhanced tools are created at much smaller sizes than one of a human cell. With the help of these tools researchers and clinicians may detect the brutal disease of cancer in an earlier stage and move on with its treatment with fewer side effects; potentially cure it before it causes irreversible damage.
- Track 3-1Nanoparticles and Thermal Ablation
- Track 3-2Non specific, Localized Use of Nanoparticles for Tumor Ablation
- Track 3-3Targeted Nanoparticle to Specific Sites for Tumor Ablation
- Track 3-4Invivo Anticancer Platform Delivery
Tissue engineering represents an emerging interdisciplinary field that applies the principles of biological, chemical, and engineering sciences towards the goal of tissue regeneration. Creating platforms that copy the design of tissue at the nanoscale is one of the significant difficulties in the field of tissue building. The advancement of nanofibers has significantly improved the degree for creating frameworks that can conceivably address this difficulty. Currently, there are three techniques for the synthesis of nanofibers: electrospinning, self-assembly, and phase separation. Of these techniques, electrospinning is the most widely studied technique and has also demonstrated the most promising results in terms of tissue engineering applications. The major application of nanofiber is that it can be used in controlled drug delivery.
- Track 4-1Tissue Regeneration
- Track 4-2Composition and Types of Nanofibers
- Track 4-3Techniques for Synthesis of Nanofibers
- Track 4-4Nanofiber Application in Tissue Engineering
- Track 4-5Nanofiber Application in Controlled Drug Delivery
Materials science is vital to nanotechnology since the properties of electronic photonic and magnetic materials can change significantly when things are made to a great degree little. This perception isn't just that we have to quantify such properties or grow new preparing apparatuses to create nanodevices, nanosensors and nanosystems. Or maybe, our vision is that the wide (and at times sudden) assortment of wonders related with nanostructured materials enable us to imagine drastically new gadgets and applications that must be made with biocompatible materials.
- Track 5-1Basic Principle and Applications
- Track 5-2Electronic, Photonic and Magnetic materials
- Track 5-3Energy Materials
- Track 5-4Nanosensors and Nanosystems
- Track 5-5Biocompatible Materials
The treatment of neurodegenerative disorders remains a colossal test because of the restricted access of atoms over the blood brain barrier, particularly vast particles, for example, peptides and proteins. Therefore, at most, a little level of a medication that is directed foundationally will achieve the focal sensory system in its dynamic shape. Noninvasive methodologies, for example, nanostructured protein conveyance transporters and intranasal organization, appear to be the most encouraging procedures for the treatment of endless infections, which require long haul mediations. These methodologies are both target-particular and ready to quickly sidestep the blood-brain barrier by means of polymeric micelles or nanogels.
- Track 6-1Neurodegenerative Disorders
- Track 6-2Bioimaging of the CNS
- Track 6-3Barriers to CNS Drug Delivery
- Track 6-4Nanocarriers for CNS Drug Delivery
- Track 6-5Polymeric Micelles
- Track 6-6Nanogels
There are various applications and methods where nanotechnology helps or enhances implants and surgical instrument design. Nanotechnology offers a dream for a 'shrewd' medication way to deal with battling tumors: the capacity of nanoparticles to find growth cells and obliterate them with single-cell accuracy. A standout amongst the most critical applications for such nanoparticulate sedate conveyance could be the conveyance of the medication payload into the cerebrum and reconstructive surgery. In any case, crossing the blood-cerebrum obstruction – the brain defensive shield – is an impressive test. With the assistance of extraordinary nanoparticles, this ends up plainly conceivable.
- Track 7-1Reconstructive Surgery
- Track 7-2Implant and Surgical Instrument Design
- Track 7-3Minimizing Surgical Damage
- Track 7-4Post surgical and Other Wound Healing
- Track 7-5Intracellular Nanosurgery
3D cell culture, recapitulating the length scale of naturally occurring nanotopographic structures, are now being used to elucidate how physical cues can direct cell behaviour and orchestrate complex cellular processes such as stem cell differentiation and tissue organization. Advances in nanotechnology have unlocked our ability to create stimuli-responsive interfaces for spatially and temporally controlling extracellular physical and biochemical cues. Synthetic, natural and cellularised nanofiber scaffolds are used for intracellular sensing and delivery at the sub-cellular level. The field of nanoengineered cell–material interface is rapidly evolving, carrying with it the potential for major breakthroughs in fundamental cellular studies and regenerative medicine.
- Track 8-13D Cell Culture and the Issues of Scale and Purity
- Track 8-2Synthetic Nanofiber Scaffold
- Track 8-3Natural Nanofiber Scaffold
- Track 8-4Cellularised Nanofiber Scaffold
- Track 8-5Other Nanotechnology based Cell Culture System
- Track 8-6Stem Cell Application
Drug delivery systems are engineered technologies for the targeted drug delivery and/or controlled release of therapeutic agents. Drugs have long been used to improve health and extend lives. Biomedical engineers have contributed substantially to our understanding of the physiological barriers to efficient drug delivery, such as transport in the circulatory system and drug movement through cells and tissues; they have also contributed to the development several targeting strategies of drug delivery that have entered clinical practice.
- Track 9-1Formulation of Nanodrugs
- Track 9-2Targeted Drug Delivery
- Track 9-3Routes of Delivery
- Track 9-4Delivery Vehicles
- Track 9-5Liposome Nanoparticle and Targeting Inflammation
Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include synthesis and self assembly of nanomaterials, advanced drug delivery systems, new therapies, and nanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, since nanomedicine must be biocompatible for clinical application.
- Track 10-1Synthesis and Self-Assembly of Nanomaterials
- Track 10-2Nanoscale Characterisation
- Track 10-3Nanobiotechnology
- Track 10-4Nanocomposites and Nanomagnetism
- Track 10-5Molecular Nanotechnology
- Track 10-6Commercialization of Nanotechnology
Polymer nanotechnology plays an essential role in synthesizing nanoscale structures and devices. The most important advance in polymer science may be polymers that are doped with nanometre-sized particles to achieve properties superior to conventional polymers. Nanotechnology, polymer matrix based nanocomposites have become a prominent area of current research and development. Research of polymers and nanotechnology primarily focuses on efforts to design materials at a molecular level to achieve desirable properties and applications at a macroscopic level such as polymer-based biomaterials, drug carrier system, nanomedicine, nanoemulsion particles, fuel cell electrode polymer bound catalysts, layer-by-layer self-assembled polymer films, smart polymer, electrospun nanofabrication, imprint lithography, polymer blends, and variety of polymer nanocomposites.
- Track 11-1Polymeric Nanoparticles
- Track 11-2Liposomes
- Track 11-3Drug Carrier System
- Track 11-4Polymer Nanocomposites
- Track 11-5Variety of Polymer Nanocomposites
- Track 11-6Smart Polymer
Nanotheranostics is a burgeoning field in recent years, which makes use of “nanotechnology” for diagnostics and therapy of different diseases. The advent of nanotheranostics is expected to benefit the pharmaceutical and healthcare industries in the next 5-10 years. Nanotechnology holds an immense potential to be explored as a multifunctional platform for a wide range of biological and engineering applications such as molecular sensors for disease diagnosis, therapeutic agents for the treatment of diseases, and a vehicle for delivering therapeutics and imaging agents for theranostic applications in cells and living animals.
- Track 12-1Nanoparticle Platforms for Theranostics
- Track 12-2Cancer Nanomedicine
- Track 12-3Nanoprobes and Contrast Agents
- Track 12-4Theranostics-Based Personalized Medicine
- Track 12-5Nanosensors for Biomarker Detection
- Track 12-6Molecular Imaging
- Track 12-7Fluorescence Real-Time Imaging
- Track 12-8Image-Guided Surgery
- Track 12-9Magnetodynamic Therapy
Pharmaceutical Nanotechnology based system deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor’s signaling and activity. Pharmaceutical nanotechnology embraces applications of nanoscience to pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.
- Track 13-1Nano-Definitions
- Track 13-2Opportunities and Scope
- Track 13-3Pharmaceutical Nanotechnology Based Systems
- Track 13-4Characterization of Pharmaceutical Nanotools
- Track 13-5Engineering of Pharmaceutical Nanosystems
- Track 13-6Applications of Pharmaceutical Nanotools
- Track 13-7Challenges to Pharmaceutical Nanotechnology
- Track 13-8Future Prospects of Pharmaceutical Nanotechnology
One of the simplest medical nanomaterials is a surface perforated with holes, or nanopores. These pores are large enough to allow small molecules such as oxygen, glucose, and insulin to pass but are small enough to impede the passage of much larger immune system molecules such as immunoglobulins and graft-borne virus particles. Hybrid “nanodevice” composed of 4.5-nm nanocrystals of biocompatible titanium dioxide semiconductor covalently attached with snippets of oligonucleotide DNA. Both single-walled and multiwalled carbon nanotubes are also being investigated as biosensors; for example, to detect glucose, ethanol, hydrogen peroxide, selected proteins such as immunoglobulins, and an electrochemical DNA hybridization biosensor.
- Track 14-1Nanopores
- Track 14-2Molecular Imprinting
- Track 14-3Quantum Dots and Nanocrystals
- Track 14-4Fullerenes and Nanotubes
- Track 14-5Nanoshells and Magnetic Nanopores
- Track 14-6Dendrimer Based Device
- Track 14-7Carbon Nanotubes
The advent of molecular nanotechnology will again expand enormously the effectiveness, comfort, and speed of future medical treatments while at the same time significantly reducing their risk, cost, and invasiveness. MNT will allow doctors to perform direct in vivo surgery on individual human cells. The ability to design, construct, and deploy large numbers of microscopic medical nanorobots will make this possible. Nanobearings and nanogears are perhaps the most convenient class of components to design because their structure and operation is straightforward.
- Track 15-1Nanorobot Parts and Components
- Track 15-2Self Assembly and Directed Parts Assembly
- Track 15-3Positional Assembly and Molecular Manufacturing
- Track 15-4Nanobearings and Nanogears
- Track 15-5Nanomotors and power sources
- Track 15-6 Nanocomputers
The use of nanotechnology to human social insurance, offers various potential pathways to enhancing therapeutic determination and treatment and even to recover tissues and organs. It can totally change the human services segment for the people to come. Nanotechnology will help medicinal experts in the present most intense therapeutic issues, for example, repairing of harmed organs, conclusion and treatment of disease cells, expulsion of obstacle in cerebrum and it can help in better medication conveyance framework. Nanotechnology can be utilized for both in vivo and in vitro biomedical research and applications. Nano particles can be utilized as a part of focusing on tumor cells at beginning stage. Nanotechnology can be utilized to create ''signature protein'' to treat tumor.
- Track 16-1Preventive Medicine
- Track 16-2Antimicribials
- Track 16-3Nanotweezers
- Track 16-4Regenerative Medicine
- Track 16-5Twisted Care at the Nanoscale
- Track 16-6Enhanced Discovery Through Therapeutic Imaging
Nanomedicine is promising remarkable things, including great advancements in the treatment of cancer. Imagine a world where there is no donor organ shortage. Where victims of spinal cord injuries can walk, where weakened hearts are replaced. This is the long-term promise of regenerative medicine, a rapidly developing field with the potential to transform the treatment of human disease through the development of innovative new therapies that offer a faster, more complete recovery with significantly fewer side effects or risk of complications.
- Track 17-1Nanorobotics and Nanomedicine
- Track 17-2Personalized Nanomedicine
- Track 17-3Nanonephrology
- Track 17-4Nanoneural Interfaces
- Track 17-5Optical Imaging at the Nanoscale
Nanomedicine offers the possibility of new diagnostic, treatment and preventive methods that may open up promising areas of medicine. The scope of this Opinion is ethical issues raised by nanomedicine in the sense indicated by the European Science Foundation definition quoted in the introduction. Fundamental values and rights are rooted in the principle of human diginity and shed light on core Europeon values, such as integrity, autonomy, privacy, equity, fairness, pluralism and solidarity.
- Track 18-1Problems and Concerns
- Track 18-2Toxicology and Human Health
- Track 18-3Risk Governance
- Track 18-4Precautionary Principle
- Track 18-5Research Policies